Trial Profile
Examination for Cardiac function Effect by Echocardiography in Diabetes with chronic heart failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Oct 2020
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Chronic heart failure; Diabetes mellitus
- Focus Therapeutic Use
- Acronyms EXCEED
- 25 Oct 2020 Status changed from recruiting to completed.
- 22 Oct 2017 Status changed from not yet recruiting to recruiting.
- 03 Jul 2017 New trial record